ALG5 Activators
ALG5 Activators are a class of compounds that enhance the enzymatic function of ALG5, a protein involved in the N-linked glycosylation pathway. Dolichyl phosphate and UDP-glucose are foundational substrates in this pathway, directly participating in the reactions facilitated by ALG5. An increase in their concentrations can lead to a proportionate increase in ALG5 activity by delivering more substrate for its catalytic action. Similarly, divalent cations such as Mn2+ and Mg2+ serve as essential cofactors, potentially enhancing ALG5's affinity for substrates or its catalytic efficiency, thereby accelerating the glycosylation process.
Secondarily, compounds that modulate other steps in the glycosylation pathway, like tunicamycin or swainsonine, may indirectly influence ALG5 activity. Although tunicamycin is a glycosylation inhibitor, it could lead to compensatory cellular responses that enhance the activity of enzymes downstream, such as ALG5, to overcome the blockage. Inhibitors like swainsonine impact mannosidase, leading to a buildup of oligosaccharide precursors that require further processing, potentially increasing the workload for ALG5. Other inhibitors, such as castanospermine and deoxynojirimycin, which target glucosidases, could also lead to an indirect increase in ALG5 activity by causing an accumulation of glycoproteins with incomplete glycan structures.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Uridine 5′-diphosphoglucose disodium salt from Saccharomyces cerevisiae | 28053-08-9 | sc-222402 sc-222402A | 10 mg 25 mg | $27.00 $34.00 | ||
UDP-glucose serves as a direct glucose donor in the reaction catalyzed by ALG5. By increasing the concentration of UDP-glucose, the glycosylation process can be enhanced, indirectly stimulating ALG5 activity. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
MnCl2 is a cofactor for some glycosyltransferase enzymes. By providing Mn2+ ions, it can enhance the enzymatic activity of glycosyltransferases, including ALG5, thus promoting the glycosylation process. | ||||||
Kinetin | 525-79-1 | sc-207780 sc-207780A | 1 g 5 g | $38.00 $48.00 | ||
Kinetin riboside can enhance the synthesis of N-linked glycans by acting on the glycosylation process. While not directly affecting ALG5, its role in promoting overall glycosylation can result in a higher demand for ALG5 activity. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Castanospermine inhibits glucosidase I and II, leading to the accumulation of glycoproteins with untrimmed glucose residues. This could indirectly stimulate ALG5 activity by increasing the pool of substrates that require the addition of glucose. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Deoxynojirimycin is a glucosidase inhibitor. By inhibiting the removal of glucose residues from glycoproteins, it can create a feedback mechanism that enhances the demand for ALG5’s enzymatic action. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the Golgi apparatus, leading to a block in the transport and modification of glycoproteins. This can cause a build-up of glycosylation precursors in the cytoplasm, potentially increasing the requirement for ALG5 activity. | ||||||
D-Glucosamine | 3416-24-8 | sc-278917A sc-278917 | 1 g 10 g | $201.00 $779.00 | ||
Glucosamine is a substrate for the synthesis of UDP-GlcNAc, which is a substrate for dolichol-P-GlcNAc transferase. By increasing UDP-GlcNAc availability, glucosamine can indirectly enhance the demand for ALG5 activity, as it is downstream in the glycosylation pathway. | ||||||
EPZ6438 | 1403254-99-8 | sc-507456 | 1 mg | $66.00 | ||
EPZ-6438 is an EZH2 inhibitor that can lead to changes | ||||||